Teleflex Announces Second Quarter 2022 Earnings Conference Call Information
Teleflex Incorporated (NYSE: TFX) is set to host a conference call on July 28, 2022, at 8:00 a.m. ET to discuss its second quarter financial results and provide an operational update.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Teleflex Incorporated (NYSE: TFX) is set to host a conference call on July 28, 2022, at 8:00 a.m. ET to discuss its second quarter financial results and provide an operational update. Participants can pre-register using a provided link or access the live audio webcast on the company’s website. An audio replay will be available after the call. Teleflex is a global provider of medical technologies aimed at improving health outcomes, with products in various medical fields, including vascular access and anesthesia.
Positive
- Scheduled conference call to discuss second quarter performance
- Opportunity for investors to gain insights on operational updates
Negative
- None.
Details
News Market Reaction – TFX
The recorded move for TFX in the trading session of this news was -1.41%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WAYNE, Pa., July 14, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, July 28, 2022.
To participate in the conference call, please utilize this link to pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company’s website, teleflex.com.
An audio replay of the call will be available beginning at 11:00 am Eastern Time on July 28, 2022, either on the Teleflex website or by telephone. The call can be accessed by dialing (866) 813-9403 (U.S.), 1 226 828 7578 (Canada), 0204 525 0658 (UK), 44 204 525 0658 (all other locations). The access code is 245144.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, LMA®, Pilling®, QuikClot®, Rüsch®, UroLift®, and Weck® – trusted brands united by a common sense of purpose.
Contacts:
Lawrence Keusch
Vice President, Investor Relations and Strategy Development
John Hsu, CFA Vice President, Investor Relations
investors.teleflex.com
610-948-2836
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.